---

Stéphane Bancel

Chief Executive Officer, Moderna Therapeutics 

Prior to Moderna, Stéphane was CEO of bioMérieux and he has also held leadership positions at Eli Lilly. Moderna claims it can generate proteins needed to treat an array of diseases by turning cells into “drug factories” with custom-built strands of messenger RNA. In 2017, Stéphane was named Ernst & Young 2017 New England Entrepreneur of the Year.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018